XML 35 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Share Based Payment
12 Months Ended
Dec. 31, 2024
Share Based Payment [Abstract]  
SHARE BASED PAYMENT

NOTE 11 - SHARE BASED PAYMENT:

 

The Company maintains a share-based payment plan for employees, directors and consultants (the “Plan”). According to the Plan, the Company can grant options and RSUs. The options and the RSUs vest over a period of up to four years, and the options’ term period is 7-10 years. Nevertheless, the Board of Directors is qualified to resolve on different vesting terms. Below is a summary of the Company’s share option and RSUs activity during the years 2024, 2023 and 2022:

 

Date of grant   Amount     Exercise
price ($) (*)
    Fair value
at the date
of grant
(U.S. dollars
in thousands)
    Volatility     Risk-free
interest rate
    Contractual
term
(in years)
 
2024                                    
Options                                    
January 1, 2024     100,000       0.00-0.43       63       0%-80.00 %     3.59 %     3-7  
March 13, 2024     45,012       0.00-1.09       59       0%-86.21 %     3.89 %     2-7  
July 16, 2024     100,000      
-
      287      
-
     
-
      5  
September 25, 2024     660,024      
-
      783      
-
     
-
      3-7  
      905,036                                          
RSUs                                                
January 1, 2024     50,000      
-
      39      
-
     
-
         
March 13, 2024     190,044      
-
      347      
-
     
-
         
July 16, 2024     55,020      
-
      158      
-
     
-
         
September 9, 2024     199,992      
-
      210      
-
     
-
         
September 25, 2024     1,750,152      
-
      2,078      
-
     
-
         
November 24, 2024     152,040      
-
      226      
-
     
-
         
      2,397,248                                          
2023                                                
Options                                                
April 20, 2023     100,000       0.20       10       79.84 %     4.14 %     2  
May 18, 2023     30,000       0.21       3       89.91 %     3.94 %     10  
November 27, 2023     1,343,748       0.00-0.43       414       91.46 %     4.17 %     7  
      1,473,748                                          
RSUs                                                
July 19, 2023     100,000      
-
      26      
-
     
-
         
September 13, 2023     650,000      
-
      209      
-
     
-
         
November 27, 2023     925,572      
-
      494      
-
     
-
         
      1,675,572                                          
2022                                                
Options                                                
March 13, 2022     84,000       0.66       59       93.01 %     2.08 %     10  
May 30, 2022     323,000       0.00-0.57       125       92.55 %     2.57 %     10  
August 31, 2022     228,000       0.47       63       91.14 %     2.97 %     10  
November 28, 2022     1,673,060       0.34       295       91.09 %     3.30 %     10  
December 19, 2022     1,020,000       0.41       116       90.78 %     3.37 %     10  
December 21, 2022     20,000       0.29       2       90.78 %     3.47 %     10  
      3,348,060                                          

 

(*)Translated from NIS based on the U.S. dollars/NIS exchange rate as of December 31, 2024.

The fair value of the options was determined using the binomial model. Volatility is based on volatility data of the traded share price of the Company. The early exercise multiple used for the fair value calculations for grants during 2024, 2023 and 2022 is 2.5 for each offeree. The fair value of RSUs and options with a zero-exercise price was estimated based on the share price on the grant date.

 

Movement in the number of share options and RSUs outstanding and their related weighted average exercise prices are as follows:

 

Options

 

   2024   2023   2022 
   Number of
options
   Average
exercise
price ($)
   Number of
options
   Average
exercise
price ($)
   Number of
options
   Average
exercise
price ($)
 
Outstanding at beginning of year:   7,136,720    0.67    7,001,800    0.88    4,235,525    1.52 
Granted   905,036    0.06    1,473,748    0.34    3,348,060    0.40 
Exercised   (2,917,879)   1.23    (224,463)   0.10    (46,561)   
-
 
Forfeited   (262,845)   0.42    (768,269)   0.56    (277,196)   1.51 
Expired   (28,066)   0.67    (346,096)   1.08    (258,028)   4.52 
Outstanding at end of year   4,832,966    0.47    7,136,720    0.67    7,001,800    0.88 
Exercisable at end of year   2,548,439    0.66    3,605,391    1.09    2,087,181    1.31 

 

RSUs

 

    2024     2023  
    Number of
RSUs
    Number of
RSUs
 
Outstanding at beginning of year:     1,675,572      
-
 
Granted     2,397,248       1,675,572  
Vested     (508,898 )    
-
 
Forfeited     (279,180 )    
-
 
Outstanding at end of year     3,284,742       1,675,572  

 

The following table summarizes information about exercise price and the remaining contractual life of options outstanding at the end of 2024, 2023 and 2022:

 

   2024   2023   2022 
Exercise prices ($)  Number
outstanding
at end of
year
   Remaining
contractual
life
(in years)
   Number
outstanding
at end of
year
   Remaining
contractual
life
(in years)
   Number
outstanding
at end of
year
   Remaining
contractual
life
(in years)
 
0.00   1,059,009    1.20-6.73    972,728    0.15-6.91    589,668    0.15-9.42 
0.21-1.09   3,119,610    0.03-8.38    3,783,920    6.91-9.39    3,118,060    9.20-9.97 
1.23-1.77   654,347    0.25-6.65    2,380,072    0.65-7.72    3,294,072    0.59-8.65 
    4,832,966         7,136,720         7,001,800      

 

Shares issuance

 

During the year ended December 31, 2024, 2,917,879 options were exercised into 2,917,879 ordinary shares for total consideration of $3,200 thousand, and 508,898 vested RSUs were issued into 508,898 ordinary shares.

 

During the year ended December 31, 2023, 224,463 options were exercised into 224,463 ordinary shares for total consideration of $23 thousand.

During the year ended December 31, 2022, 46,561 options were exercised into 46,561 ordinary shares for no consideration. Also, the Company issued 140,135 ordinary shares to service providers for a total estimated fair value of $104 thousand.

 

Expenses recognized in the financial statements

 

The costs which were recognized in the Company’s financial statements in respect of services received from its employees and consultants are presented in the table below:

 

   Year ended December 31 
   2024   2023   2022 
   U.S. dollar in thousands 
Share-based payment plans   2,017    933    1,679 

 

The plans are intended to be governed under rules set for that purpose in the Plan. The exercise prices of the options that are exercisable into shares as of December 31, 2024, range between $0.00 to $1.77.